Subscribe To
Hollywood writers approve strike if union talks break down
By Lisa Richwine and Danielle Broadway LOS ANGELES (Reuters) -Hollywood writers voted overwhelmingly in favor of giving union negotiators the power to...
April 17, 2023, 10:33 pm
Aon approves 10% dividend hike, boosts shareholder value
Aon's (AON) recent dividend hike reinforces its solid financial position and intensified focus to enhance shareholders' value....
April 17, 2023, 1:43 pm
Peabody energy makes gains on $1b share buyback program
Peabody Energy stock moved higher after the company announced the repurchase of up to $1 billion of its common stock as part of a newly...
April 17, 2023, 11:19 am
Merck's $10.8 billion prometheus deal has citi analysts bullish
Prometheus' PRA023 drug can add 15% to 30% to Merck's long-term earnings once approved, according to Ci...
April 17, 2023, 8:56 am
Australian court approves bhp’s $6.4 billion oz minerals takeover
(Reuters) – Global miner BHP Group Ltd said on Monday the Federal Court of Australia had approved its...
April 17, 2023, 3:19 am
Russia’s war on ukraine latest: putin meets chinese defence minister in moscow
(Reuters) – The International Monetary Fund said its executive board had approved a four-year $15.6 b...
April 16, 2023, 5:13 pm
The 4 best banks for small business loans (2023)
Banks are the least likely lender to approve a borrower’s business loans. In the second quarter of 20...
April 16, 2023, 1:44 pm
Russia’s war on ukraine latest: unprecedented bloodshed in bakhmut, ukraine says
(Reuters) – The International Monetary Fund said its executive board had approved a four-year $15.6 b...
April 16, 2023, 5:58 am
Russia’s war on ukraine latest: russia says wagner fighters seize two more parts of bakhmut
(Reuters) – The International Monetary Fund said its executive board had approved a four-year $15.6 b...
April 15, 2023, 5:15 pm
Russia’s war on ukraine latest: russian missiles kill 9 in ukraine
(Reuters) – The International Monetary Fund said its executive board had approved a four-year $15.6 b...
April 15, 2023, 11:12 am
Fed approves ubs's acquisition of u.s. subsidiaries of credit suisse
The Federal Reserve on Friday announced its approval for UBS Group AG to acquire the U.S. subsidiaries of Credit Suisse Group. As part of the agreemen...
April 14, 2023, 4:20 pm
Stratasys (ssys) rejects nano's revised takeover offer
Stratasys (SSYS) disapproves Nano Dimensions' takeover proposal again, citing that the bid price significantly undermines its valuation and the ongoin...
April 14, 2023, 10:40 am
2 monster growth stocks that can double in value, according to wall street
Intellia Therapeutics is a gene-editing company with lots of potential if it can get an approved treatm...
April 14, 2023, 5:19 am
Biden admin greenlights lng exports from alaska project -document
By Timothy Gardner WASHINGTON (Reuters) – The Biden administration on Thursday approved exports of li...
April 14, 2023, 2:46 am
Russia’s war on ukraine latest: attacks on bakhmut relentless, kyiv says borders must be restored
(Reuters) – The International Monetary Fund said its executive board had approved a four-year $15.6 b...
April 14, 2023, 2:20 am
Japan approves osaka as site of country’s first casino
By Kantaro Komiya TOKYO (Reuters) -Japan on Friday approved a plan to build the country’s first casin...
April 14, 2023, 1:16 am
Sabina gold & silver shareholders approve proposed b2gold acquisition of the company for approximately c$1.2 billion
Sabina Gold & Silver (TSX:SBB) announced today that shareholders approved a special resolution to proce...
April 13, 2023, 4:25 pm
Plx pharma inc. enters into a stalking horse asset purchase agreement to sell vazalore® and substantially all of its assets
SPARTA, N.J., April 12, 2023 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), is a commercial-stage drug delivery...
April 12, 2023, 9:24 pm
Can axsome hold out till depression drug becomes a blockbuster?
Auvelity, a drug newly approved for major depressive disorder, could exceed $1 billion in sales by 2029...
April 12, 2023, 8:35 am
X4 pharmaceuticals: chronic neutropenia might finally have met its match
Positive P3 results of mavorixafor for first-ever treatment of WHIM syndrome with possible BLA approval in 1H 2024. A large chronic neutropenia market...
April 12, 2023, 4:29 am